SAN FRANCISCO, Oct. 26, 2023 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW) announced one-year results from CLASP IID, the first randomized controlled trial that directly compares two ...
BOSTON, Sept. 17, 2022 /PRNewswire/ -- Edwards Lifesciences Corporation (EW) announced results from CLASP IID, the first randomized controlled trial that directly compares two contemporary ...
Transcatheter edge-to-edge repair (TEER), a minimally invasive surgery, has emerged as a low-risk treatment option for various types of mitral regurgitation. TEER has demonstrated its efficacy by ...
(6mm width) Central spacer helps reduce tension on mitral leaflets and promotes better leaflet coaptation Three independent movement components on the delivery system that enhances flexibility and ...
NEW YORK CITY -- Newer technology strengthened the case for single-shot transcatheter edge-to-edge repair (TEER) for concomitant mitral regurgitation (MR) and tricuspid regurgitation (TR), according ...
Patients with heart failure and atrial fibrillation (AF) at the time of mitral transcatheter edge-to-edge repair (M-TEER) for severe mitral regurgitation are more than twice as likely to die or be ...
Transcatheter edge-to-edge repair (TEER) is associated with lower mortality and heart failure hospitalization rates among elderly patients with atrial functional mitral regurgitation compared to ...
Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results